Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comment on "Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence".

Malik Zubair Hussain1, Anas Ahmed1, Majid Khattak1

  • 1Shaikh Khalifa Bin Zayed Al-Nahyan Medical College, Shaikh Zayed Postgraduate Medical Institute (SZPGMI), Lahore, Pakistan.

Neurourology and Urodynamics
|May 7, 2026
PubMed
Summary

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to Editor on: "Trends and Racial/Ethnic Disparities in Pharmacologic and Surgical Management of Treated Female Patients With Urinary Incontinence".

Neurourology and urodynamics·2026
Same author

Re: Cost of Managing Proximal Humerus Fractures in Road Traffic Injuries.

ANZ journal of surgery·2026
Same journal

Does Gestational Diabetes Increase Urinary Incontinence During Pregnancy? A Cross-Sectional Study of Symptom Patterns and Incontinence-Related Quality of Life.

Neurourology and urodynamics·2026
Same journal

Fascial Mild Urethral Sling or Artificial Urinary Sphincter in the Neurological Women Population, a Multicenter Study.

Neurourology and urodynamics·2026
Same journal

Elucidating Characteristics of Co-Existent Overactive and Underactive Bladder in Participants of the 2023 Japan Community Health Survey (JaCS 2023) With Nocturia.

Neurourology and urodynamics·2026
Same journal

Urodynamic Voiding Patterns in Multiple Sclerosis.

Neurourology and urodynamics·2026
Same journal

Urodynamic and Anamnestic Predictors for Individual Dose Adjustment of Intravesical Oxybutynin in Neurogenic Detrusor Overactivity: Results From the UPSIDE Study.

Neurourology and urodynamics·2026
Same journal

Letter to the Editor on "Effect of Acupressure on Anxiety, Embarrassment, and Procedural Fear in Patients Undergoing Urodynamic Testing: Randomized Controlled Study".

Neurourology and urodynamics·2026
See all related articles
This summary is machine-generated.

Bulkamid injections show promise for stress incontinence, but the study had limitations. Further research with objective outcomes is needed to confirm effectiveness and guide clinical decisions.

Area of Science:

  • Urology
  • Female Pelvic Medicine

Background:

  • Urethral bulking agents like Bulkamid are gaining traction for stress incontinence management.
  • Real-world evidence suggests effectiveness, prompting further investigation.
Keywords:
Bulkamidfemale pelvic medicinemethodological limitationsminimally invasive therapypatient‐reported outcomesselection biasstress urinary incontinencetreatment outcomesurethral bulking agentsurodynamics

Related Experiment Videos